-
1por Cocca, Massimiliano, Bedognetti, Davide, La Bianca, Martina, Gasparini, Paolo, Girotto, Giorgia“…In particular, for trastuzumab two variants were detected: (1) rs1801274-G within FCGR2A and associated with decreased efficacy (LOE 2B); (2) rs1136201-G located within ERBB2 and associated with increased toxicity (LOE 3). …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto